Future Coagulation Testing Market: Growth Opportunities and Business Expansion Strategies 8

Future Coagulation Testing Market: Growth Opportunities and Business Expansion Strategies

Published : Dec-2011

Description

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

This comprehensive worldwide study is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the coagulation market during the next decade. The study explores business and technological trends in major markets; provides estimates of the test volume, instrument placements and installed base; as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.

Introduction

Worldwide Market and Technology Overview

A.Major Routine and Special Coagulation Tests
- 1. Introduction
- 2. Activated Partial Thromboplastin Time (APTT)
- 3. Alpha-2 Antiplasmin
- 4. Antithrombin III
- 5. Bleeding Time
- 6. D-Dimer
- 7. Ethanol Flocculation Test
- 8. Euglobulin Lysis
- 9. Factor Assays
  - a. Introduction
  - b. Factor II
  - c. Factor V/Factor V Leiden
  - d. Factor VII
  - e. Factor VIII
  - f. Factor IX
  - g. Factor IXa
  - h. Factor X (Stuart Factor)
  - i. Factor Xa
  - j. Factor XI
  - k. Factor XII
  - l. Factor XIII
- 10. Fibrin Degradation Products
- 11. Fibrinogen
- 12. Heparin
- 13. Hirudin
- 14. Hypercoagulability and Thrombosis
- 15. Lipoprotein a
- 16. Plasmin
- 17. Plasminogen
- 18. Plasminogen Activator Inhibitor (PAI)
- 19. Platelet Function Tests
- 20. Platelet Aggregation
- 21. Proteins C and S
- 22. Prothrombin Fragment 1.2
- 23. Prothrombin Time (PT)
- 24. Reptilase Time
- 25. Thrombin Time
- 26. Tissue-Type Plasminogen Activator (t-PA)
- 27. Von Willebrand’s Factor
B. Instrumentation Review
- Introduction
- Benk Hemolab
- Benk TRT Thrombotimer
- Bio/Data MCA 310
- Bio/Data MCA 210
- Bio/Data PAP-4C D/4D/4C
- Cardiovascular Diagnostics COAG
- Diagnostica Stago STA Compact
- Diagnostica Stago STA-R
- Diagnostica Stago Star 4/8
- Helena Laboratories Cascade 480
- Helena Laboratories Cascade M
- Helena Laboratories PACKS-4
- Helena THOR
- Instrumentation Laboratory ACL 100 and 1000 series
- Instrumentation Laboratory ACL6000
- Instrumentation Laboratory ACL7000
- Instrumentation Laboratory ACL9000
- Instrumentation Laboratory Electra 1000C
- Instrumentation Laboratory Electra 1400C
- Instrumentation Laboratory Electra 1600/C
- Instrumentation Laboratory Electra 1800C
- Instrumentation Laboratory Futura
- ITC Hemochron 8000
- Roche Diagnostics CoaguChek
- Siemens BCS
- Siemens BCT
- Siemens BF II/Fibrintimer Series
- Sysmex CA-50
- Sysmex CA-500
- Sysmex CA-1500
- Sysmex CA-5000/CA-1000
- Sysmex CA-6000
- Sysmex CA-7000
- Teco Coatron II/Jr./AccuStasis 5000
- Trinity Biotech Amax CS190
- Trinity Biotech Amax CS400
- Trinity Biotech Coag-A-Mate Max
- Trinity Biotech KC 40, 4A, 1A Series
- Trinity Biotech MDA 180
- Trinity Biotech Coag-A-Mate MTX
- Trinity Biotech Coag-A-Mate RA4
- Trinity Biotech Coag-A-Mate XC/Plus
- Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
- 1. Chromogenic Substrates
- 2. Monoclonal and Polyclonal Antibodies
- 3. Immunoassays
  - a. Applications
  - b. Technological Principle
  - c. Enzyme Immunoassays (EIA)
    - Overview
    - ELISA
    - EMIT
    - Dot Immunobinding Assays
    - Capillary Immunoassays
    - Enzyme Amplification
    - Electrochemical Immunoassay
  - d. Fluorescent Immunoassays
    - Fluorescence Polarization
    - Time-Resolved Pulse Fluorescence
    - Fluorescence Lifetime
  - e. Latex Agglutination
  - f. Immunoprecipitation
- 4. Microcomputers
- 5. Automation
- 6. Robotics
- 7. DNA Probes
  - a. Overview
  - b. Amplification Methods
    - PCR
    - Ligase Chain Reaction
    - Branched DNA
    - Q-Beta Replicase
    - NASBA
    - SDA
    - 3 SR
    - HPA
    - Two-Tiered System
    - LAT
- 8. Artificial Intelligence
- 9. Dry Chemistry
- 10. Biosensors
D.Worldwide Market Overview
- 1. Business Environment
- 2. Market Structure
- 3. Market Size and Growth
- 4. POC Testing Market

France

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

Germany

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

Italy

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

Japan

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

Spain

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

UK

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

USA

A. Executive Summary
B.Business Environment
- 1. Health Care Expenditures
- 2. Cost Consciousness
- 3. Industry Consolidation
- 4. Managed Care
- 5. Hospitals
- 6. Admissions
- 7. Length of Stay
- 8. Industry Diversification
- 9. Physician Demographics
- 10. Population Aging
  - a. Chronic Illnesses
  - b. Disease Incidence
  - c. Susceptibility to Iatrogenesis
  - d. Multiple Illness Cases
- 11. Laboratory Regulations
C.Market Structure
- 1. Centralized Testing
  - a. Hospitals
  - b. Commercial laboratories
- 2. Decentralized Testing
  - a. Physician Offices/Group Practices
  - b. Point-of-Care Testing
- c. Home/Self Testing
  - d. Other Decentralized Testing Locations
  - D. Market Size, Growth And Major Suppliers

Major Product Development Opportunities

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
- 1. Marketing Approaches
- 2. Product Complexity
- 3. Customer Preference
- 4. Established Suppliers
- 5. Emerging Suppliers
- 6. Major Types Of Distributors
- 7. Market Segmentation

Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

Competitive Assessments

Abbott
American Diagnostica
Avocet Medical
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Biosite
Chrono-Log
Corgenix Medical
Diagnostica Stago
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Nanogen
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
Trinity Biotech

ZyCare

List of Tables

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand’s Factor Tests

Worldwide, All Market Segments, Laboratories Performing Coagulation Tests By Country, 2010
Worldwide, All Market Segments, Total Coagulation Test Volume By Country, 2010-2020
Worldwide, All Market Segments, Total Coagulation Reagent Market By Country, 2010-2020
Worldwide, All Market Segments, Total Coagulation Instrument Market By Country, 2010-2020
Worldwide, All Market Segments, Total Coagulation Diagnostics Market By Country, 2010-2020

Executive Summary Table: France, Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
France, Laboratories Performing Coagulation Tests By Market Segment, 2010
France, Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
France, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
France, Hospital Laboratories Average Daily Test Volume, 2010
France, Commercial/Private Laboratories Average Daily Test Volume, 2010
France, Total Coagulation Test Volume By Market Segment, 2010-2020
France, All Market Segments Coagulation Test Volume, 2010-2020
France, Hospital Laboratories Coagulation Test Volume, 2010-2020
France, Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
France, Coagulation Reagent Market By Market Segment, 2010-2020
France, Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2010
France, Coagulation Instrument Market By Market Segment, 2010-2020
France, Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
France, Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
France, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
France, Total Coagulation Diagnostics Market By Product Category, 2010-2020
France, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010

Executive Summary Table: Germany, Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
Germany, Laboratories Performing Coagulation Tests By Market Segment, 2010
Germany, Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
Germany, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
Germany, Hospital Laboratories Average Daily Test Volume, 2010
Germany, Commercial/Private Laboratories Average Daily Test Volume, 2010
Germany, Physician Offices/Group Practice Average Daily Test Volume, 2010
Germany, Total Coagulation Test Volume By Market Segment, 2010-2020
Germany, All Market Segments Coagulation Test Volume, 2010-2020
Germany, Hospital Laboratories Coagulation Test Volume, 2010-2020
Germany, Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
Germany, Physician Offices/Group Practices Coagulation Test Volume, 2010-2020
Germany, Coagulation Reagent Market By Market Segment, 2010-2020
Germany, Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares, 2010
Germany, Coagulation Instrument Market By Market Segment, 2010-2020
Germany, Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
Germany, Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
Germany, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
Germany, Total Coagulation Diagnostics Market By Product Category, 2010-2020
Germany, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010

Executive Summary Table: Italy, Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
Italy, Laboratories Performing Coagulation Tests By Market Segment, 2010
Italy, Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
Italy, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
Italy, Hospital Laboratories Average Daily Test Volume, 2010
Italy, Commercial/Private Laboratories Average Daily Test Volume, 2010
Italy, Total Coagulation Test Volum By Market Segment, 2010-2020
Italy, All Market Segments Coagulation Test Volume, 2010-2020
Italy, Hospital Laboratories Coagulation Test Volume, 2010-2020
Italy, Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
Italy, Coagulation Reagent Market By Market Segment, 2010-2020
Italy, Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2010
Italy, Coagulation Instrument Market By Market Segment, 2010-2020
Italy, Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
Italy, Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
Italy, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
Italy, Total Coagulation Diagnostics Market By Product Category, 2010-2020
Italy, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010

Executive Summary Table: Japan, Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
Japan, Laboratories Performing Coagulation Tests By Market Segment, 2010
Japan, Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
Japan, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
Japan, Hospital Laboratories Average Daily Test Volume, 2010
Japan, Commercial/Private Laboratories Average Daily Test Volume, 2010
Japan, Total Coagulation Test Volume By Market Segment, 2010-2020
Japan, All Market Segments Coagulation Test Volume, 2010-2020
Japan, Hospital Laboratories Coagulation Test Volume, 2010-2020
Japan, Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
Japan, Coagulation Reagent Market By Market Segment, 2010-2020
Japan, Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2010
Japan, Coagulation Instrument Market By Market Segment, 2010-2020
Japan, Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
Japan, Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
Japan, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
Japan, Total Coagulation Diagnostics Market By Product Category, 2010-2020
Japan, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010

Executive Summary Table: Spain, Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
Spain, Laboratories Performing Coagulation Tests By Market Segment, 2010
Spain, Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
Spain, Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
Spain, Hospital Laboratories Average Daily Test Volume, 2010
Spain, Ambulatory Care Centers Average Daily Test Volume, 2010
Spain, Commercial/Private Laboratories Average Daily Test Volume, 2010
Spain, Total Coagulation Test Volume By Market Segment, 2010-2020
Spain, All Market Segments Coagulation Test Volume, 2010-2020
Spain, Hospital Laboratories Coagulation Test Volume, 2010-2020
Spain, Ambulatory Care Centers Coagulation Test Volume, 2010-2020
Spain, Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
Spain, Coagulation Reagent Market By Market Segment, 2010-2020
Spain, Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares, 2010
Spain, Coagulation Instrument Market By Market Segment, 2010
Spain, Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
Spain, Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
Spain, Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
Spain, Total Coagulation Diagnostics Market By Product Category, 2010-2020
Spain, Major Suppliers of Coagulation Diagnostic Products, Estimates Sales and Market Shares, 2010

Executive Summary Table: U.K., Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
U.K., Laboratories Performing Coagulation Tests By Market Segment, 2010
U.K., Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
U.K., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
U.K., Hospital Laboratories Average Daily Test Volume, 2010
U.K., Commercial/Private Laboratories Average Daily Test Volume, 2010
U.K., Total Coagulation Test Volume By Market Segment, 2010-2020
U.K., All Market Segments Coagulation Test Volume, 2010-2020
U.K., Hospital Laboratories Coagulation Test Volume, 2010-2020
U.K., Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
U.K., Coagulation Reagent Market By Market Segment, 2010-2020
U.K., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2010
U.K., Coagulation Instrument Market By Market Segment, 2010
U.K., Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
U.K., Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
U.K., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
U.K., Total Coagulation Diagnostics Market By Product Category, 2010-2020
U.K., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010

Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category, 2010-2020
U.S.A., Laboratories Performing Coagulation Tests By Market Segment, 2010
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size, 2010
U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume, 2010
U.S.A., Physician Offices/Group Practices Performing Coagulation Tests By Practice Size, 2010
U.S.A., Hospital Laboratories Average Daily Test Volume, 2010
U.S.A., Commercial/Private Laboratories Average Daily Test Volume, 2010
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Coagulation Test Volume By Market Segment, 2010-2020
U.S.A., All Market Segments Coagulation Test Volume, 2010-2020
U.S.A., Hospital Laboratories Coagulation Test Volume, 2010-2020
U.S.A., Physician Offices/Group Practices Coagulation Test Volume, 2010-2020
U.S.A., Commercial/Private Laboratories Coagulation Test Volume, 2010-2020
U.S.A., Coagulation Reagent Market By Market Segment, 2010-2020
U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares, 2010
U.S.A., Coagulation Instrument Market By Market Segment, 2010-2020
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Total Instrument Placements and Market Shares, 2010
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Placements and Installed Base By Supplier and Model, 2010
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares, 2010
U.S.A., Total Coagulation Diagnostics Market By Product Category, 2010-2020

U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares, 2010

Filed in: In Vitro Diagnostic

Tags: Venture Planning Group

Name:
Email:
Phone:
Subject:
Comments:

Mobile Television Market To Propel Due To Mounting Use Of Tablets And Smartphones

The increasing practice of smartphones and tablets universally has assisted in an increase in the mobile television market. Maximum smartphones and tablets nowadays are TV empowered and this has given...

Inventions Propel Wearable Medical Devices Market

The launch of medical wearable devices has enhanced the growth of the global medical devices market. Major players in the global medical devices market are busy in mechanizing trailblazing yet economi...

Global End-of-line Packaging Market To Become Innovative Owing To Automation

The global end-of-line packaging market is set for massive upheaval in the coming years. The intensity of competition in the market is predicted to upsurge as the manufacturers are concentrating on in...

Global Medical Robotics Market To Gain From Increased Adoption By The Geriatric Population

Medical robotics is up-and-coming area of healthcare. An extensive range of medical applications has materialized like laboratory robots, surgical robots, telesurgery, remote surgery, and teleconsulta...

Agribots In High Demand As Cultivators Look For Superior Farming Methods

Robots and drones have, at present, started to gently alter many facets of agriculture. This is by now a US$ 3 billion market in 2016 and is expected to grow to US$10 billion by 2022. Robotics has see...

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500